LATIN AMERICA

Latin America includes a portfolio of locally recognised and trusted brands sold across the public and private sector. Brazil and Mexico are the biggest contributors to regional performance.

Key Countries

Brazil
Chile
Colombia
Ecuador
Mexico

The Brazilian private pharmaceutical market declined 3%, negatively impacted by foreign exchange movements and was valued by IQVIA at USD26 billion, while the Brazilian pharmaceutical market in local currency grew 11% for the year 30 June 2020.

Source: IQVIA – June 2020

STATISTICS

Number of products launched:

6

(2019: 8)

Average staff turnover*:

27%

(2019: 25%)

Number of product recalls:

Nil

(2019: Nil)

Number of work-related fatalities:

Nil

(2019: Nil)

* Rate excludes employees transferred in Nutritionals disposal.

Number of permanent employees

736

June 2020

773

June 2019

Revenue	2020 R’million	2019 (CER) R’million	Change %
Regional Brands	2 342	2 136	10
Sterile Focus Brands	1 070	957	12
Anaesthetics Brands	994	882	13
Thrombosis Brands	76	75	1

Total	3 412	3 093	10

Note: Commercial Pharmaceuticals revenue is disclosed by customer geography.